Is aggressive treatment of smoldering myeloma the path to curing myeloma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is aggressive treatment of smoldering myeloma the path to curing myeloma?

Published:2023-07-27 Issue:15 Volume:7 Page:3932-3935
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Chakraborty Rajshekhar¹^ORCID,Al Hadidi Samer²,Scheffer Cliff Edward R.³^ORCID,Mohyuddin Ghulam Rehman⁴^ORCID

Affiliation:

1. 1Multiple Myeloma and Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY

2. 2Myeloma Section, Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, Little Rock, AR

3. 3Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

4. 4Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, UT

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/15/3932/2069690/blooda_adv-2023-009658-main.pdf

Reference32 articles.

1. Prevalence of smoldering multiple myeloma based on nationwide screening;Thorsteinsdóttir;Nat Med,2023

2. Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma;Mateos;N Engl J Med,2013

3. Randomized trial of lenalidomide versus observation in smoldering multiple myeloma;Lonial;J Clin Oncol,2020

4. Curative strategy (GEM-CESAR) for high-risk smoldering myeloma (SMM): post-hoc analysis of sustained undetectable measurable residual disease (MRD);Mateos;Blood,2022

5. Fixed duration therapy with daratumumab, carfilzomib, lenalidomide and dexamethasone for high risk smoldering multiple myeloma-results of the ascent trial;Kumar;Blood,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating early intervention in smoldering myeloma clinical trials: a systematic review;The Oncologist;2024-09-05

2. Clinical trials of T-cell re-directing therapy in plasma cell precursor conditions;European Journal of Cancer;2024-05

3. IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA?;Mediterranean Journal of Hematology and Infectious Diseases;2024-04-30

4. Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey;eClinicalMedicine;2023-11

5. Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma;Frontiers in Immunology;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3